<?xml version="1.0" encoding="UTF-8"?>
<p>The third drug is probably the best viral fusion inhibitor, RS 504393, which can bind both the SARS-CoV-2 S protein and its receptor ACE2 and is used for treating lung injury and bronchial wall thickening; moreover, it is also a selective antagonist of the monocyte chemoattractant protein-1 (MCP-1) receptor CCR2, blocks the upregulation of pronociceptive, pro-inflammatory interleukins IL-1Î², IL-18, IL-6, and as such are very useful for decreasing the 'cytokine storm' and the associated neuropathic pain (patients hypersensitive to touch).</p>
